share_log

啓明醫療-B：董事會召開日期 及 繼續暫停買賣

VENUS MEDTECH-B: DATE OF BOARD MEETING AND CONTINUED SUSPENSION OF TRADING

香港交易所 ·  Mar 18 10:31
Summary by Moomoo AI
根據啓明醫療-B（股份代號：2500）最新公告，公司董事會計劃於2024年3月28日（星期四）召開會議，審議及批准截至2023年12月31日止年度的全年業績及其發佈，並將考慮是否派發末期股息。此外，公司股份自2023年11月23日起已暫停在香港聯合交易所有限公司（聯交所）買賣，暫停買賣將持續至符合聯交所的復牌指引為止。公司股東及潛在投資者應注意買賣本公司證券時需審慎行事。目前，公司執行董事包括林浩昇先生、馬力喬先生及柳美榮女士；非執行董事為張奧先生及王瑋先生；獨立非執行董事為胡定旭先生及孫志偉先生。
根據啓明醫療-B（股份代號：2500）最新公告，公司董事會計劃於2024年3月28日（星期四）召開會議，審議及批准截至2023年12月31日止年度的全年業績及其發佈，並將考慮是否派發末期股息。此外，公司股份自2023年11月23日起已暫停在香港聯合交易所有限公司（聯交所）買賣，暫停買賣將持續至符合聯交所的復牌指引為止。公司股東及潛在投資者應注意買賣本公司證券時需審慎行事。目前，公司執行董事包括林浩昇先生、馬力喬先生及柳美榮女士；非執行董事為張奧先生及王瑋先生；獨立非執行董事為胡定旭先生及孫志偉先生。
According to the latest announcement by Kai Ming Medical -B (Stock Code: 2500), the Company's Board of Directors plans to hold a meeting on Thursday, March 28, 2024, to review and approve the annual results for the year ended December 31, 2023, and will consider whether to issue a final dividend. In addition, the company's shares have been suspended from 23 November 2023 on the Stock Exchange of Hong Kong Limited (HKEx) and the suspension of trading will continue until they comply with the Exchange's Recollection Guidelines. Shareholders and potential investors should be aware of the need to exercise caution when buying and selling our securities. CURRENTLY, THE EXECUTIVE DIRECTORS OF THE COMPANY INCLUDE MR. LIN HAO SHENG, MR. MA LI CHAO AND MS. LIU MEI-WING; NON-EXECUTIVE DIRECTORS ARE MR. ZHANG AO AND MR. WANG WEI; INDEPENDENT NON-EXECUTIVE DIRECTORS ARE MR. HU DING-XU AND MR. SUN CHI WAI.
According to the latest announcement by Kai Ming Medical -B (Stock Code: 2500), the Company's Board of Directors plans to hold a meeting on Thursday, March 28, 2024, to review and approve the annual results for the year ended December 31, 2023, and will consider whether to issue a final dividend. In addition, the company's shares have been suspended from 23 November 2023 on the Stock Exchange of Hong Kong Limited (HKEx) and the suspension of trading will continue until they comply with the Exchange's Recollection Guidelines. Shareholders and potential investors should be aware of the need to exercise caution when buying and selling our securities. CURRENTLY, THE EXECUTIVE DIRECTORS OF THE COMPANY INCLUDE MR. LIN HAO SHENG, MR. MA LI CHAO AND MS. LIU MEI-WING; NON-EXECUTIVE DIRECTORS ARE MR. ZHANG AO AND MR. WANG WEI; INDEPENDENT NON-EXECUTIVE DIRECTORS ARE MR. HU DING-XU AND MR. SUN CHI WAI.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more